VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 51 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -88.9% | 300 | -82.4% | 0.00% | – |
| Q2 2020 | $18,000 | 0.0% | 1,700 | 0.0% | 0.00% | – |
| Q1 2020 | $18,000 | -33.3% | 1,700 | 0.0% | 0.00% | – |
| Q4 2019 | $27,000 | -46.0% | 1,700 | -50.0% | 0.00% | – |
| Q3 2019 | $50,000 | +163.2% | 3,400 | +100.0% | 0.00% | – |
| Q2 2019 | $19,000 | +5.6% | 1,700 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | +38.5% | 1,700 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -51.9% | 1,700 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 108,794 | $1,252,000 | 0.47% |
| Perceptive Advisors | 3,410,412 | $39,254,000 | 0.42% |
| KNOTT DAVID M | 76,585 | $881,000 | 0.40% |
| Fosun International Ltd | 324,061 | $3,730,000 | 0.24% |
| Orbimed Advisors | 1,479,733 | $17,032,000 | 0.15% |
| SteelPeak Wealth, LLC | 132,961 | $1,530,000 | 0.14% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 665,511 | $7,660,000 | 0.13% |
| Capital Investment Advisory Services, LLC | 15,125 | $174,000 | 0.03% |
| BECK MACK & OLIVER LLC | 10,000 | $115,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 335,318 | $3,860,000 | 0.00% |